Cargando…

Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease

Moyamoya disease (MMD) and moyamoya syndrome (MMS) are progressive vascular pathologies unique to the cerebrovasculature that are important causes of stroke in both children and adults. The natural history of MMD is characterized by primary progressive stenosis of the supraclinoid internal carotid a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fox, Brandon M., Dorschel, Kirsten B., Lawton, Michael T., Wanebo, John E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446194/ https://www.ncbi.nlm.nih.gov/pubmed/34539540 http://dx.doi.org/10.3389/fneur.2021.661578

Ejemplares similares

Corrigendum: Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease
por: Fox, Brandon M., et al.
Publicado: (2021)

Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases
por: Dorschel, Kirsten B., et al.
Publicado: (2023)

Genetic and Proteomic Contributions to the Pathophysiology of Moyamoya Angiopathy and Related Vascular Diseases
por: Dorschel, Kirsten B, et al.
Publicado: (2021)

Burden of dilated perivascular spaces in patients with moyamoya disease and moyamoya syndrome is related to middle cerebral artery stenosis
por: Han, Guangsong, et al.
Publicado: (2023)

Editorial: Moyamoya disease
por: Gu, Yuxiang
Publicado: (2022)

APOE as potential biomarkers of moyamoya disease
por: Wu, Haibin, et al.
Publicado: (2023)

Non-invasive Urinary Biomarkers in Moyamoya Disease
por: Sesen, Julie, et al.
Publicado: (2021)

The Pathophysiology of Moyamoya Disease: An Update
por: Bang, Oh Young, et al.
Publicado: (2016)

Moyamoya: An Update and Review
por: Berry, James A, et al.
Publicado: (2020)

Influence of Inflammatory Disease on the Pathophysiology of Moyamoya Disease and Quasi-moyamoya Disease
por: MIKAMI, Takeshi, et al.
Publicado: (2019)

Indirect revascularization vs. non-surgical treatment for Moyamoya disease and Moyamoya syndrome: A comparative effectiveness study
por: Wang, Yixuan, et al.
Publicado: (2022)

RNF213 and GUCY1A3 in Moyamoya Disease: Key Regulators of Metabolism, Inflammation, and Vascular Stability
por: Mineharu, Yohei, et al.
Publicado: (2021)

Moyamoya Disease: A Review of Current Literature
por: Gupta, Apurv, et al.
Publicado: (2020)

Application of DTI and fMRI in moyamoya disease
por: Hao, Xiaokuan, et al.
Publicado: (2022)

Increased Autoimmunity in Individuals With Down Syndrome and Moyamoya Disease
por: Santoro, Jonathan D., et al.
Publicado: (2021)

Moyamoya Disease in a Six Month Caucasian Female
por: Moore, Faith D, et al.
Publicado: (2020)

Editorial: Moyamoya disease – natural history and therapeutic challenges
por: Svedung Wettervik, Teodor, et al.
Publicado: (2023)

Moyamoya Disease in a Young Female With Neurofibromatosis Type 1
por: Mehkri, Yusuf, et al.
Publicado: (2021)

Clinical and Radiological Outcomes After Revascularization of Hemorrhagic Moyamoya Disease
por: Kang, Kaijiang, et al.
Publicado: (2020)

Angiographic Outcomes of Direct and Combined Bypass Surgery in Moyamoya Disease
por: Ge, Peicong, et al.
Publicado: (2019)

Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment
por: Zhang, Xin, et al.
Publicado: (2022)

Clinical value of the systemic immune-inflammation index in moyamoya disease
por: Liu, Erheng, et al.
Publicado: (2023)

Epidemiology of Moyamoya Angiopathy in Eastern India
por: Das, Shambaditya, et al.
Publicado: (2022)

Moyamoya Disease in a 13-Month-Old Middle Eastern Boy
por: M. Ali, Nashwa, et al.
Publicado: (2021)

Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease
por: Ye, Fei, et al.
Publicado: (2021)

MMP-9 as a Biomarker for Predicting Hemorrhagic Strokes in Moyamoya Disease
por: Lu, Junlin, et al.
Publicado: (2021)

A Patient With Multiple Sclerosis and Coexisting Moyamoya Disease: Why and How
por: Si, Xiaoli, et al.
Publicado: (2020)

Cerebral Hemodynamic Changes After Revascularization in Patients With Hemorrhagic Moyamoya Disease
por: Kang, Kaijiang, et al.
Publicado: (2020)

Caveolin-1 Promoted Collateral Vessel Formation in Patients With Moyamoya Disease
por: Zhao, Jinbing, et al.
Publicado: (2022)

Natural course and risk factors of moyamoya disease with unruptured intracranial aneurysm
por: Yang, Ri-Miao, et al.
Publicado: (2023)

Western Moyamoya Phenotype: A Scoping Review
por: Miller, Raphael, et al.
Publicado: (2021)

Surgical Management of Failed Revascularization in Moyamoya Vasculopathy
por: Lucia, Kristin, et al.
Publicado: (2021)

Pathophysiology of Vascular Remodeling in Hypertension
por: Renna, Nicolás F., et al.
Publicado: (2013)

Extracranial and Intracranial Vasculopathy With “Moyamoya Phenomenon” in Association With Alagille Syndrome
por: Delaney, Siobhan, et al.
Publicado: (2019)

Hemorrhagic Transformation in Ischemic Moyamoya Disease: Clinical Characteristics, Radiological Features, and Outcomes
por: Lu, Junlin, et al.
Publicado: (2020)

Hyperhomocysteinemia Is a Predictor for Poor Postoperative Angiogenesis in Adult Patients With Moyamoya Disease
por: He, Qiheng, et al.
Publicado: (2022)

The relationship between hemoglobin and triglycerides in moyamoya disease: A cross-sectional study
por: Su, Yu, et al.
Publicado: (2022)

Potential predictors for progression of moyamoya disease: A systematic review and meta-analysis
por: Cao, Jun, et al.
Publicado: (2023)

Incidental Moyamoya Disease in an Elderly Patient Presenting With Acute Ischemic Pontine Stroke
por: Abou-El-Hassan, Hadi, et al.
Publicado: (2023)

A Case Report of Moyamoya Disease Presenting as Recurrent Right-Sided Weakness
por: Khan, Nabila T, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mjot2ui91i0of7tebdo5pol5bp